Danny Gauvreau, Sarah J Dolman, Greg Hughes, Paul D O'Shea, Ian W Davies
Index: J. Org. Chem. 75(12) , 4078-85, (2010)
Full Text: HTML
The evolution of scalable, economically viable synthetic approaches to the potent and selective prostaglandin EP4 antagonist 1 is presented. The chromatography-free synthesis of multikilogram quantities of 1 using a seven-step sequence (six in the longest linear sequence) is described. This approach has been further modified in an effort to identify a long-term manufacturing route. Our final synthesis involves no step requiring cryogenic (< -25 degrees C) conditions; comprises a total of four steps, only three of which are in the longest linear synthesis; and features the use of two consecutive iron-catalyzed Friedel-Crafts substitutions.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
Cyclopropanamine
CAS:765-30-0 |
C3H7N |
|
Synthesis and antibacterial activity of some novel 4-oxopyri...
2014-11-01 [Arch. Pharm. (Weinheim) 347(11) , 861-72, (2014)] |
|
Cyclopropylamines from N,N-dialkylcarboxamides and Grignard ...
2010-12-10 [Chemistry 16 , 13862-13875, (2010)] |
|
Cyclopropylamine inactivation of cytochromes P450: role of m...
2005-04-15 [Arch. Biochem. Biophys. 436(2) , 265-75, (2005)] |
|
The Kulinkovich reaction in the synthesis of constrained n,n...
2007-05-10 [Org. Lett. 9(10) , 1987-90, (2007)] |
|
Mutation of surface cysteine 374 to alanine in monoamine oxi...
2005-05-16 [Bioorg. Med. Chem. 13(10) , 3487-95, (2005)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2026 ChemSrc All Rights Reserved
